BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18616919)

  • 1. [Effects of activated PPARgamma on the expression of PTEN gene in pancreatic cancer cells].
    Bai MH; Ma HB; Wang XJ; Liu XX; Xue XH; Xue FJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Jul; 24(7):717-20. PubMed ID: 18616919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue of glandular dysmorphogenesis in PTEN-deficient colorectal cancer epithelium by PPARγ-targeted therapy.
    Jagan I; Fatehullah A; Deevi RK; Bingham V; Campbell FC
    Oncogene; 2013 Mar; 32(10):1305-15. PubMed ID: 22543585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-γ inhibits pancreatic cancer cell invasion and metastasis via regulating MMP-2 expression through PTEN.
    Li Y; Zhang DW; Lin DQ; Cao LQ
    Mol Med Rep; 2015 Oct; 12(4):6255-60. PubMed ID: 26299428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPARgamma activator rosiglitazone inhibits cell migration via upregulation of PTEN in human hepatocarcinoma cell line BEL-7404.
    Zhang W; Wu N; Li Z; Wang L; Jin J; Zha XL
    Cancer Biol Ther; 2006 Aug; 5(8):1008-14. PubMed ID: 16775433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells.
    Cao LQ; Chen XL; Wang Q; Huang XH; Zhen MC; Zhang LJ; Li W; Bi J
    Acta Pharmacol Sin; 2007 Jun; 28(6):879-87. PubMed ID: 17506947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effect of PPARγ in sepsis-induced acute lung injury via inhibiting PTEN/β-catenin pathway.
    Liu L; Chen J; Zhang X; Cui X; Qiao N; Zhang Y; Yang J
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32420586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17beta-estradiol induces up-regulation of PTEN and PPARgamma in leiomyoma cells, but not in normal cells.
    Jeong YJ; Noh EM; Lee YR; Yu HN; Jang KY; Lee SJ; Kim J; Kim JS
    Int J Oncol; 2010 Apr; 36(4):921-7. PubMed ID: 20198337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal expression of PTEN and PIK3CA in pemetrexed-resistant human pancreatic cancer cell line Patu8988.
    Shi X; Gu HT; Lin SB; Zhang Y; Yang J; Qian CJ
    Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the PTEN promoter by statins and SREBP.
    Teresi RE; Planchon SM; Waite KA; Eng C
    Hum Mol Genet; 2008 Apr; 17(7):919-28. PubMed ID: 18065496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
    Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
    Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagy.
    To KKW; Wu WKK; Loong HHF
    Eur J Pharmacol; 2018 Mar; 823():19-26. PubMed ID: 29378193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone.
    Teresi RE; Shaiu CW; Chen CS; Chatterjee VK; Waite KA; Eng C
    Int J Cancer; 2006 May; 118(10):2390-8. PubMed ID: 16425225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone upregulates PTEN expression and induces the apoptosis of pulmonary artery smooth muscle cells under hypoxic conditions.
    Pi WF; Guo XJ; Su LP; Xu WG
    Int J Mol Med; 2013 Nov; 32(5):1101-9. PubMed ID: 24026200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPARgamma independent mechanisms.
    Galli A; Ceni E; Crabb DW; Mello T; Salzano R; Grappone C; Milani S; Surrenti E; Surrenti C; Casini A
    Gut; 2004 Nov; 53(11):1688-97. PubMed ID: 15479693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of peroxisome proliferator-activated receptor gamma inhibits the growth of human pancreatic cancer.
    Sasaki T; Fujimoto Y; Tsuchida A; Kawasaki Y; Kuwada Y; Chayama K
    Pathobiology; 2001; 69(5):258-65. PubMed ID: 12107343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor γ ligands retard cultured vascular smooth muscle cells calcification induced by high glucose.
    Zhou YB; Zhang J; Peng DQ; Chang JR; Cai Y; Yu YR; Jia MZ; Wu W; Guan YF; Tang CS; Qi YF
    Cell Biochem Biophys; 2013 Jul; 66(3):421-9. PubMed ID: 23274912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
    Lin MS; Chen WC; Bai X; Wang YD
    J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPAR-gamma modulates allergic inflammation through up-regulation of PTEN.
    Lee KS; Park SJ; Hwang PH; Yi HK; Song CH; Chai OH; Kim JS; Lee MK; Lee YC
    FASEB J; 2005 Jun; 19(8):1033-5. PubMed ID: 15788448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR-gamma agonist increase gefitinib's antitumor activity through PTEN expression.
    Lee SY; Hur GY; Jung KH; Jung HC; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
    Lung Cancer; 2006 Mar; 51(3):297-301. PubMed ID: 16386327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
    Nakano R; Kurosaki E; Yoshida S; Yokono M; Shimaya A; Maruyama T; Shibasaki M
    Biochem Pharmacol; 2006 Jun; 72(1):42-52. PubMed ID: 16696951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.